RPI supports AstraZeneca in advancing the care of patients living with B-cell malignancies
In July 2026, Research Power Inc. was in London with the AstraZeneca Hem-Oncology UK leadership and Key Account Management team focused on advancing the care of patients living with B-cell malignancies. Over the course of 2 days, RPI worked with the UK team in reviewing and discussing the key data presented at the European Hematology […]